N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide

C35H34F3N5O2 — CID 11505414

IUPACN-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide
SMILESCCc1ccc(-c2nc3c(N4CCN(CCOc5ccc(NC(=O)c6ccccc6C(F)(F)F)cc5)CC4)cccc3[nH]2)cc1
InChIInChI=1S/C35H34F3N5O2/c1-2-24-10-12-25(13-11-24)33-40-30-8-5-9-31(32(30)41-33)43-20-18-42(19-21-43)22-23-45-27-16-14-26(15-17-27)39-34(44)28-6-3-4-7-29(28)35(36,37)38/h3-17H,2,18-23H2,1H3,(H,39,44)(H,40,41)
InChIKeyRZLMGFYDSDVUMH-UHFFFAOYSA-N
MW613.68 g/mol
LogP7.26
Rot. Bonds9

About N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide

N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide (PubChem CID 11505414) has the molecular formula C35H34F3N5O2 and a molecular weight of 613.68 g/mol. Its IUPAC name is N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide.

Molecular Properties

Compound NameN-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide
PubChem CID11505414
Molecular FormulaC35H34F3N5O2
Molecular Weight613.68 g/mol
Exact Mass613.27
IUPAC NameN-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide
SMILESCCc1ccc(-c2nc3c(N4CCN(CCOc5ccc(NC(=O)c6ccccc6C(F)(F)F)cc5)CC4)cccc3[nH]2)cc1
InChIInChI=1S/C35H34F3N5O2/c1-2-24-10-12-25(13-11-24)33-40-30-8-5-9-31(32(30)41-33)43-20-18-42(19-21-43)22-23-45-27-16-14-26(15-17-27)39-34(44)28-6-3-4-7-29(28)35(36,37)38/h3-17H,2,18-23H2,1H3,(H,39,44)(H,40,41)
InChIKeyRZLMGFYDSDVUMH-UHFFFAOYSA-N
XLogP7.26
TPSA73.49 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500613.68
LogP ≤ 57.26
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide?
The IUPAC name of N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide (CID 11505414) is N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide.
What is the SMILES notation for N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide?
The canonical SMILES for N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide is CCc1ccc(-c2nc3c(N4CCN(CCOc5ccc(NC(=O)c6ccccc6C(F)(F)F)cc5)CC4)cccc3[nH]2)cc1.
What is the InChIKey of N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide?
The InChIKey is RZLMGFYDSDVUMH-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H34F3N5O2/c1-2-24-10-12-25(13-11-24)33-40-30-8-5-9-31(32(30)41-33)43-20-18-42(19-21-43)22-23-45-27-16-14-26(15-17-27)39-34(44)28-6-3-4-7-29(28)35(36,37)38/h3-17H,2,18-23H2,1H3,(H,39,44)(H,40,41).
What are the key properties of N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide?
N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide has a molecular weight of 613.68 g/mol, XLogP of 7.26, 9 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[2-[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]ethoxy]phenyl]-2-(trifluoromethyl)benzamide is sourced from PubChem (CID 11505414), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).